Evolution of self-reactive IgG antibody repertoires in patients with relapsing-remitting multiple sclerosis

Immunology Letters

Volumn 97, Issue 1, 2005, Pages 55-62

  Lionel, Almeras ^a   De Seze, J ^a,b   Didier, Lefranc ^a   Sandrine, Fily Nalewajk ^a   Sylvain, Dubucquoi ^a   Patrick, Vermersch ^b   Lionel, Prin ^a  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Autoantibody; Interferon beta; Multiple sclerosis

Indexed keywords

BETA INTERFERON; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BRAIN; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ADULT; AUTOANTIBODIES; BRAIN; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 11144305030     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.09.014     Document Type: Article

References (36)

1. C.S. Raine Multiple sclerosis: a pivotal role for the T cell in lesion development Neuropathol Appl Neurobiol 17 1991 265 274
2. P.D. Giles, J.P. Heath, and S.J. Wroe Oligoclonal bands and the IgG index in multiple sclerosis: uses and limitations Ann Clin Biochem 26 1989 1317 1323
3. C. Lucchinetti, W. Bruck, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination Ann Neurol 47 2000 707 717
4. F. Fazekas, F. Deisenhammer, S. Strasser-Fuchs, G. Nahler, and B. Mamoli Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group Lancet 349 1997 589 593
5. A. Achiron, U. Gabbay, R. Gilad, S. Hassin-Baer, Y. Barak, M. Gornish, A. Elizur, Y. Goldhammer, and I. Sarova-Pinhas Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses Neurology 50 1998 398 402
6. P.S. Sorensen, B. Wanscher, C.V. Jensen, K. Schreiber, M. Blinkenberg, M. Ravnborg, H. Kirsmeier, V.A. Larsen, and M.L. Lee Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis Neurology 50 1998 1273 1281
7. G. Martino, T. Olsson, S. Fredrikson, B. Hojeberg, V. Kostulas, L.M. Grimaldi, and H. Link Cells producing antibodies specific for myelin basic protein region 70-89 are predominant in cerebrospinal fluid from patients with multiple sclerosis Eur J Immunol 21 1991 2971 2976
8. J.J. Archelos, J. Trotter, S. Previtali, B. Weissbrich, K.V. Toyka, and H.P. Hartung Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis Ann Neurol 43 1998 15 24
9. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group Neurology 43 1993 655 661
10. L.D. Jacobs, D.L. Cookfair, R.A. Rudick, R.M. Herndon, J.R. Richert, A.M. Salazar, J.S. Fischer, D.E. Goodkin, C.V. Granger, J.H. Simon, J.J. Alam, D.M. Bartoszak, D.N. Bourdette, J. Braiman, C.M. Brownscheidle, M.E. Coats, S.L. Cohan, D.S. Dougherty, R.P. Kinkel, M.K. Mass, F.E. Munschauer III, R.L. Priore, P.M. Pullicino, B.J. Scherokman, and R.H. Whitham Intramuscular interferon β-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) Ann Neurol 39 1996 285 294
11. B.G. Arnason Immunologic therapy of multiple sclerosis Annu Rev Med 50 1999 291 302
12. ® (IFNβ-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group J Neuroimmunol 93 1999 8 14
13. M.A. Farrar, and R.D. Schreiber The molecular cell biology of interferon-γ and its receptor Annu Rev Immunol 11 1993 571 611
14. A. Noronha, A. Toscas, and M.A. Jensen Interferon β decreases T cell activation and interferon γ production in multiple sclerosis J Neuroimmunol 46 1993 145 153
15. R.A. Rudick, and R.M. Ransohoff Biologic effects of interferons: relevance to multiple sclerosis Mult Scler 1 Suppl 1 1995 12 16
16. H. Tilg, and A. Kaser Interferons and their role in inflammation Curr Pharm Des 5 1999 771 785
17. D. Lefranc, L. Almeras, S. Dubucquoi, J. de Seze, P. Vermersch, and L. Prin Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis, as a new diagnostic tool J Immunol 172 2004 669 678
18. A.M. Francoeur, and J.G. Heitzmann Autoantibodies: terms and concepts Clin Immunol Immunopathol 47 1988 245 252
19. W.I. McDonald, A. Compston, G. Edan, D. Goodkin, H.P. Hartung, F.D. Lublin, H.F. McFarland, D.W. Paty, C.H. Polman, S.C. Reingold, M. Sandberg-Wollheim, W. Sibley, A. Thompson, S. van den Noort, B.Y. Weinshenker, and J.S. Wolinsky Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis Ann Neurol 50 2001 121 127
20. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
21. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
22. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc Natl Acad Sci USA 76 1979 4350 4354
23. G. Marshall, and A.E. Baron Linear discriminant models for unbalanced longitudinal data Statist Med 19 2000 1969 1981
24. D. Stahl, S. Lacroix-Desmazes, L. Mouthon, S.V. Kaveri, and M.D. Kazatchkine Analysis of human self-reactive antibody repertoires by quantitative immunoblotting J Immunol Meth 240 2000 1 14
25. A. Coutinho, and M.D. Kazatchkine Autoimmunity. Physiology and disease 1994 Wiley New York
26. + regulatory T cells induced by an agonist self-peptide Nat Immunol 2 2001 301 306
27. L. Mouthon, M. Haury, S. Lacroix-Desmazes, C. Barreau, A. Coutinho, and M.D. Kazatchkine Analysis of the normal human IgG antibody repertoire. Evidence that IgG autoantibodies of healthy adults recognize a limited and conserved set of protein antigens in homologous tissues J Immunol 154 1995 5769 5778
28. S. Lacroix-Desmazes, L. Mouthon, A. Coutinho, and M.D. Kazatchkine Analysis of the natural human IgG antibody repertoire: life-long stability of reactivities towards self antigens contrasts with age-dependent diversification of reactivities against bacterial antigens Eur J Immunol 25 1995 2598 2604
29. L. Mouthon, A. Nobrega, N. Nicolas, S.V. Kaveri, C. Barreau, A. Coutinho, and M.D. Kazatchkine Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults Proc Natl Acad Sci USA 92 1995 3839 3843
30. R. Dziewas, B. Kis, F.H. Grus, and C.W. Zimmermann Antibody pattern analysis in the Guillain-Barre syndrome and pathologic controls J Neuroimmunol 119 2001 287 296
31. L. Almeras, D. Lefranc, H. Drobecq, J. de Seze, S. Dubucquoi, P. Vermersch, and L. Prin New antigenic candidates in multiple sclerosis: identification by serological proteome analysis Proteomics 4 2004 2184 2194
32. M. Zaffaroni Biological indicators of the neurodegenerative phase of multiple sclerosis Neurol Sci 24 Suppl 5 2003 279 282
33. S.R. Ruuls, M.C. de Labie, K.S. Weber, C.A. Botman, R.J. Groenestein, C.D. Dijkstra, T. Olsson, and P.H. van der Meide The length of treatment determines whether IFN-β prevents or aggravates experimental autoimmune encephalomyelitis in Lewis rats J Immunol 157 1996 5721 5731
34. V.K. Tuohy, M. Yu, L. Yin, J.A. Kawczak, and R.P. Kinkel Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis J Exp Med 189 1999 1033 1042
35. B.D. Trapp, J. Peterson, R.M. Ransohoff, R. Rudick, S. Mork, and L. Bo Axonal transection in the lesions of multiple sclerosis N Engl J Med 338 1998 278 285
36. V.K. Tuohy, M. Yu, L. Yin, P.M. Mathisen, J.M. Johnson, and J.A. Kawczak Modulation of the IL-10/IL-12 cytokine circuit by interferon-β inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis J Neuroimmunol 111 2000 55 63